TREGARON SURGERY
SALOP HOUSE, CHAPEL STREET, TREGARONHF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
HF 4 | 2010 | 15 | 21 | 71.4% | |
HF 4 | 2011 | 16 | 22 | 72.7% | |
HF 4 | 2012 | 22 | 27 | 81.5% | |
HF 4 | 2013 | 23 | 26 | 88.5% | |
HF004W | 2014 | 17 | 17 | 100.0% | |
HF004 | 2015 | 26 | 27 | 96.3% |